查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1468236

2024-2032 年核醫放射性同位素市場（按產品、應用、最終用戶和地區分類）

Nuclear Medicine Radioisotopes Market by Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球核醫放射性同位素市場規模達73億美元。癌症盛行率的上升、對核醫學的需求不斷增加以及各種技術進步是推動市場的一些關鍵因素。

核子醫學放射性同位素是用於各種醫療狀況的診斷和治療過程的放射性物質。這些放射性同位素發出輻射，可以檢測和測量輻射，以提供有關體內器官和組織的結構和功能的資訊。它們主要用於診斷和治療應用。在診斷應用中，放射性同位素用於創建人體內部器官和系統的圖像。這使得醫療保健專業人員能夠識別異常並診斷癌症、心臟病和神經系統疾病等疾病。另一方面，在治療應用中，放射性同位素用於對體內的癌細胞或其他異常組織進行標靶放射治療。此外，核醫放射性同位素與傳統的診斷和治療程序相比具有多種優勢，因為它們是非侵入性的，不需要手術切口或其他侵入性程序，並且與化療或放射療法等治療相比，副作用和併發症的風險較低。由於這些優點，核醫放射性同位素在全球醫院廣泛使用。

核子醫學放射性同位素市場趨勢：

該市場主要是由個人癌症盛行率不斷上升所推動的。核醫放射性同位素廣泛應用於癌症診斷解決方案，例如 PET 掃描和治療療法。此外，越來越多的老年人口更容易罹患癌症、心臟病和神經系統疾病等慢性疾病，這些疾病需要使用核子醫學放射性同位素，這是另一個主要的生長誘導因素。除此之外，各種技術進步導致了核醫學放射性同位素新的和改進的診斷和治療應用的發展。再加上核子醫學投資和需求的增加，正在對市場成長產生正面影響。政府和私人組織正大力投資核醫技術的研發，進而創造新產品和應用，進而推動市場成長。此外，患者對放射和放射治療的認知不斷增強也推動了市場的發展。此外，醫療保健支出的增加、先進產品變體的推出以及主要參與者進行的研發活動的增加是創造有利市場前景的其他因素。

本報告回答的關鍵問題：

  • 迄今為止，全球核醫放射性同位素市場表現如何，未來幾年將如何表現？
  • 全球核醫放射性同位素市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球核醫學放射性同位素市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的核醫放射性同位素市場？
  • 基於產品的市場區隔是什麼？
  • 核子醫學放射性同位素市場中最具吸引力的產品是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 核子醫學放射性同位素市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 核醫放射性同位素市場中哪一個是最具吸引力的最終用戶？
  • 全球核醫放射性同位素市場競爭格局如何？
  • 全球核醫放射性同位素市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球核子醫學放射性同位素市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 診斷
    • 市場走向
    • 關鍵環節
      • 锝-99m (Tc-99m)
      • 鎵67
      • 鉈201
      • 氟18
      • 其他
    • 市場預測
  • 療法
    • 市場走向
    • 關鍵環節
      • 錸186
      • 碘131
      • 釤-153
      • 釔90
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 心臟病學
    • 市場走向
    • 市場預測
  • 腫瘤學
    • 市場走向
    • 市場預測
  • 甲狀腺
    • 市場走向
    • 市場預測
  • 神經病學
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 教育及科研機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bracco SpA
    • Bruce Power Inc.
    • Cardinal Health Inc.
    • China Isotope & Radiation Corporation (China National Nuclear Corporation)
    • Curium Pharma
    • Eckert & Ziegler
    • Nordion (Canada) Inc (Sotera Health Company)
    • NorthStar Medical Radioisotopes, LLC
    • NTP Radioisotopes SOC Ltd
    • Shine Technologies LLC
Product Code: SR112024A7532

The global nuclear medicine radioisotopes market size reached US$ 7.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The rising prevalence of cancer, the escalating demand for nuclear medicines, and various technological advancements represent some of the key factors driving the market.

Nuclear medicine radioisotopes are radioactive substances that are used in diagnostic and therapeutic procedures for various medical conditions. These radioisotopes emit radiation, which can be detected and measured to provide information about the structure and function of organs and tissues in the body. They are mainly utilized for diagnostic and therapeutic applications. In diagnostic applications, radioisotopes are employed to create images of the body's internal organs and systems. This allows healthcare professionals to identify abnormalities and diagnose conditions such as cancer, heart disease, and neurological disorders. On the other hand, in therapeutic applications, radioisotopes are used to deliver targeted radiation therapy to cancer cells or other abnormal tissues in the body. Moreover, nuclear medicine radioisotopes have several advantages over traditional diagnostic and therapeutic procedures as they are non-invasive, do not require surgical incisions or other invasive procedures, and have a lower risk of side effects and complications compared to treatments such as chemotherapy or radiation therapy. Owing to these benefits, nuclear medicine radioisotopes are widely utilized in hospitals across the globe.

Nuclear Medicine Radioisotopes Market Trends:

The market is primarily driven by the growing prevalence of cancer among individuals. Nuclear medicine radioisotopes are widely used in cancer diagnosis solutions such as PET scans and treatment therapies. In addition, the rising geriatric population that is more susceptible to chronic diseases such as cancer, heart disease, and neurological disorders, which require the use of nuclear medicine radioisotopes, represents another major growth-inducing factor. Besides this, various technological advancements have led to the development of new and improved diagnostic and therapeutic applications of nuclear medicine radioisotopes. This, coupled with the increasing investment and demand for nuclear medicines, is positively influencing market growth. Governments and private organizations are investing heavily in the research and development of nuclear medicine technologies, leading to the creation of new products and applications, which in turn is driving the market growth. Moreover, the market is also propelled by the growing patient awareness about radiation and radiation therapy. Furthermore, the rising healthcare expenditure, the launch of advanced product variants, and increasing research and development activities conducted by key players are other factors creating a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nuclear medicine radioisotopes market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, application, and end user.

Product Insights:

Diagnostics

Technetium-99m (Tc-99m)

Gallium-67

Thallium-201

Fluorine-18

Others

Therapeutics

Rhenium-186

Iodine-131

Samarium-153

Yttrium-90

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the product. This includes diagnostics [technetium-99m (Tc-99m), gallium-67, thallium-201, fluorine-18, and others] and therapeutics (rhenium-186, iodine-131, samarium-153, yttrium-90, and others). According to the report, diagnostics (technetium-99m (Tc-99m) represented the largest segment.

Application Insights:

Cardiology

Oncology

Thyroid

Neurology

Others

A detailed breakup and analysis of the nuclear medicine radioisotopes market based on the application has also been provided in the report. This includes cardiology, oncology, thyroid, neurology, and others. According to the report, cardiology accounted for the largest market share.

End User Insights:

Hospitals

Diagnostic Centers

Specialty Clinics

Education and Research Institutes

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the end user. This includes hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for nuclear medicine radioisotopes. Some of the factors driving the North America nuclear medicine radioisotopes market included aging population, technological advancements, rising prevalence of cancer.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global nuclear medicine radioisotopes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bracco S.p.A., Bruce Power Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (China National Nuclear Corporation), Curium Pharma, Eckert & Ziegler, Nordion (Canada) Inc (Sotera Health Company), NorthStar Medical Radioisotopes, LLC, NTP Radioisotopes SOC Ltd.,Shine Technologies LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global nuclear medicine radioisotopes market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine radioisotopes market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine radioisotopes market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the nuclear medicine radioisotopes market?
  • What is the competitive structure of the global nuclear medicine radioisotopes market?
  • Who are the key players/companies in the global nuclear medicine radioisotopes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Radioisotopes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Technetium-99m (Tc-99m)
      • 6.1.2.2 Gallium-67
      • 6.1.2.3 Thallium-201
      • 6.1.2.4 Fluorine-18
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Rhenium-186
      • 6.2.2.2 Iodine-131
      • 6.2.2.3 Samarium-153
      • 6.2.2.4 Yttrium-90
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Thyroid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neurology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Education and Research Institutes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bracco S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Bruce Power Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Cardinal Health Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 China Isotope & Radiation Corporation (China National Nuclear Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Curium Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Eckert & Ziegler
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nordion (Canada) Inc (Sotera Health Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 NorthStar Medical Radioisotopes, LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 NTP Radioisotopes SOC Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shine Technologies LLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Nuclear Medicine Radioisotopes Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Radioisotopes Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Nuclear Medicine Radioisotopes Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Nuclear Medicine Radioisotopes Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Nuclear Medicine Radioisotopes Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Nuclear Medicine Radioisotopes Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Nuclear Medicine Radioisotopes (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Nuclear Medicine Radioisotopes (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Nuclear Medicine Radioisotopes (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Nuclear Medicine Radioisotopes (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Nuclear Medicine Radioisotopes (Thyroid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Nuclear Medicine Radioisotopes (Thyroid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Nuclear Medicine Radioisotopes (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Nuclear Medicine Radioisotopes (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Nuclear Medicine Radioisotopes (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Nuclear Medicine Radioisotopes (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Nuclear Medicine Radioisotopes (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Nuclear Medicine Radioisotopes (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Nuclear Medicine Radioisotopes (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Nuclear Medicine Radioisotopes (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Nuclear Medicine Radioisotopes Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Nuclear Medicine Radioisotopes Industry: Value Chain Analysis
  • Figure 83: Global: Nuclear Medicine Radioisotopes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Radioisotopes Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Nuclear Medicine Radioisotopes Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Radioisotopes Market: Key Players